Home » Topics » Disease categories and therapies » Immune

Immune
RSS

VaxGen cleared to begin clinical testing of smallpox vaccine LC16m8

Sep. 9, 2004

Nautilus and Creabilis to develop improved variant of CT-500

Sep. 8, 2004

GW-766994 inhibits early and late phase allergic reactions

Sep. 7, 2004

Novel urea-based immunomodulators discovered at Genzyme

Sep. 7, 2004

The Ig FLC antagonist F-991 shows promise for contact allergy

Sep. 6, 2004

Immunomodulatory effects of alpha-MSH in preclinical models of allergy and hypersensitivity

Sep. 6, 2004

Vertex claims new SHP-2 phosphatase inhibitors and their use

Sep. 3, 2004

Vaccine programs progress at Sinovac

Sep. 2, 2004

MedImmune terminates rheumatoid arthritis and psoriasis trials for Vitaxin

Sep. 2, 2004

New S1P1/Edg1 agonists developed by Merck scientists

Sep. 2, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 9, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...